Apply for Funding from the CMT Research Foundation
The CMT Research Foundation funds innovative research from discovery to preclinical stages to advance therapies for all types of Charcot-Marie-Tooth disease.
Funder: CMT Research Foundation
Due Dates (Anticipated): December 2026 | February 2027 | May 2027
Funding Amounts: Typical awards: $100,000–$200,000 per year for 1–3 years; exceptional proposals may receive higher budgets; indirect costs up to 10%.
Summary: Supports innovative research and therapeutic development for all types of Charcot-Marie-Tooth disease (CMT), from early discovery to preclinical stages.
Key Information: Letter of Intent (LOI) required before full proposal; open to global academic and for-profit researchers.
Description
This funding opportunity from the CMT Research Foundation is the organization’s principal grant mechanism to accelerate the development of treatments and cures for Charcot-Marie-Tooth disease (CMT) across all subtypes. The program welcomes projects spanning early discovery, translational, and preclinical research, with a strong emphasis on proposals that align with the foundation's published research priorities. Both traditional and high-risk, high-reward ideas are encouraged, provided there is a clear rationale for therapeutic advancement. Projects must demonstrate clear milestones and a strong alignment with the foundation’s mission to deliver effective treatments for CMT.
